Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis
- 作者: Loginov V.I.1,2, Burdennyy A.M.1, Filippova E.A.1, Pronina I.V.1, Kazubskaya T.P.3, Kushlinsky D.N.3, Ermilova V.D.3, Rykov S.V.4, Khodyrev D.S.4,5, Braga E.A.1,2
-
隶属关系:
- Institute of General Pathology and Pathophysiology
- Research Center of Medical Genetics
- Blokhin Russian Cancer Research Center
- State Research Institute for Genetics and Selection of Industrial Microorganisms, Kurchatov Institute National Research Center
- Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
- 期: 卷 52, 编号 5 (2018)
- 页面: 693-700
- 栏目: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163676
- DOI: https://doi.org/10.1134/S0026893318050102
- ID: 163676
如何引用文章
详细
It is known that microRNAs (miRNAs) are able to dynamically regulate gene expression. At the same time, methylation can reduce expression of miRNA encoding genes and, therefore, reduce their inhibitory effects on mRNAs of target genes, including those of oncogenes, that promoting the development of tumors of different localization. The role of miRNA hypermethylation in the pathogenesis of ovarian cancer is not completely understood; so we conducted a search for new hypermethylated and potentially suppressor miRNA genes in ovarian tumors. Four new miRNA genes (MIR-107, MIR-130b, MIR-203a, MIR-1258) commonly hypermethylated (28‒52% ) in tumor tissues vs 4‒7% in paired histologically normal tissues, p < 0.01, were identified in a representative set of 54 ovarian cancer samples using methylation-specific PCR. It was shown that hypermethylation of MIR-130b, MIR-203a, and MIR-1258 genes is significantly (p ≤ 0.05) associated with metastasis of ovarian cancer. These results suggest the involvement of four miRNAs (miR-107, miR-130b, miR-203a, and miR-1258) and hypermethylation of their encoding genes in the pathogenesis of ovarian cancer.
作者简介
V. Loginov
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
编辑信件的主要联系方式.
Email: loginov7w@gmail.com
俄罗斯联邦, Moscowa, 125315; Moscow, 115478
A. Burdennyy
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscowa, 125315
E. Filippova
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscowa, 125315
I. Pronina
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscowa, 125315
T. Kazubskaya
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscow, 115478
D. Kushlinsky
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscow, 115478
V. Ermilova
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscow, 115478
S. Rykov
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscow, 117545
D. Khodyrev
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center; Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies,
Federal Biomedical Agency of Russia
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscow, 117545; Moscow, 115682
E. Braga
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
编辑信件的主要联系方式.
Email: eleonora10_45@mail.ru
俄罗斯联邦, Moscowa, 125315; Moscow, 115478
补充文件
